Search Results 161-170 of 12295 for fibrosis quistica
... fibrosis (IPF). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
The purpose of this study is to assess the effectiveness of a new ultrasound technique for non-invasive evaluation of liver fibrosis. Participation ...
To assess the efficacy and safety of 12 months of therapy with inhaled colistimethate sodium in the treatment of subjects with non-cystic fibrosis ...
... fibrosis, pulmonary fibrosis and pulmonary hypertension, the investigators will assess the feasibility of collecting skin biopsies from patients undergoing ...
Advances in genomics have substantially expanded understanding of the inherited basis of pulmonary fibrosis. Pathogenic variants involving telomere biology ...
... fibrosis. This study is designed to assess response to treatment on measures of fibrosis and other efficacy parameters. It will also assess dose response ...
The purpose of this study is to determine if the integrated holistic approach that combines metabo-phenotyping, gadoxetate clearance, and spleen stiffness ...
... fibrosis bronchiectasis with eosinophilic inflammation (NCFB+EI). All patients who complete the 52-week double-blind treatment period on investigational ...
Lebwohl MG, et al. Nephrogenic systemic fibrosis. In: Treatment of Skin Disease: Comprehensive Therapeutic Strategies. 5th ed.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.